Accessibility Menu
 
Varex Imaging logo

Varex Imaging

(NASDAQ) VREX

Current Price$10.53
Market Cap$439.95M
Since IPO (2017)-62%
5 Year-50%
1 Year-8%
1 Month-18%

Varex Imaging Financials at a Glance

Market Cap

$439.95M

Revenue (TTM)

$854.40M

Net Income (TTM)

$67.70M

EPS (TTM)

$-1.67

P/E Ratio

-6.30

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$10.53

Volume

3,709

Open

$10.53

Previous Close

$10.53

Daily Range

$10.46 - $10.59

52-Week Range

$6.76 - $14.56

VREX: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Varex Imaging

Industry

Healthcare Equipment and Supplies

Employees

2,400

CEO

Sunny S. Sanyal, MBA

Headquarters

Salt Lake City, UT 84104, US

VREX Financials

Key Financial Metrics (TTM)

Gross Margin

34%

Operating Margin

-3%

Net Income Margin

-8%

Return on Equity

-13%

Return on Capital

-3%

Return on Assets

-6%

Earnings Yield

-15.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$439.95M

Shares Outstanding

41.90M

Volume

3.71K

Short Interest

0.00%

Avg. Volume

332.70K

Financials (TTM)

Gross Profit

$290.50M

Operating Income

$27.80M

EBITDA

$3.50M

Operating Cash Flow

$41.70M

Capital Expenditure

$22.90M

Free Cash Flow

$18.80M

Cash & ST Invst.

$155.10M

Total Debt

$401.90M

Varex Imaging Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$209.60M

+4.9%

Gross Profit

$69.80M

+1.9%

Gross Margin

33.30%

N/A

Market Cap

$439.95M

N/A

Market Cap/Employee

$191.28K

N/A

Employees

2,300

N/A

Net Income

$2.30M

+866.7%

EBITDA

$22.20M

+24.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$275.70M

+29.1%

Accounts Receivable

$146.50M

+6.1%

Inventory

$328.00M

+17.2%

Long Term Debt

$394.90M

-33.4%

Short Term Debt

$6.40M

-27.3%

Return on Assets

-6.17%

N/A

Return on Invested Capital

-2.52%

N/A

Free Cash Flow

$26.80M

-605.7%

Operating Cash Flow

$16.10M

-269.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OFIXOrthofix Medical Inc.
$11.77+2.08%
SYSo-Young International Inc.
$2.81-2.09%
LABStandard BioTools Inc.
$0.89-1.97%
BCYCBicycle Therapeutics plc
$4.89-3.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.86-0.04%
NOKNokia
$8.93+0.01%
HOLXHologic
$76.01+0.00%
INTCIntel
$50.91+0.01%

Questions About VREX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.